193357-48-1

Basic information

• Product Name: Piperidine, 1-[2-[3-(1,3-dioxolan-2-yl)phenoxy]ethyl]-4-(phenylmethyl)-
• CAS NO: 193357-48-1
• Molecular Formula: C23H29NO3
• Molecular Weight: 367.488
• Mol File: 193357-48-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Piperidine, 1-[2-[3-(1,3-dioxolan-2-yl)phenoxy]ethyl]-4-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Piperidine, 1-[2-[3-(1,3-dioxolan-2-yl)phenoxy]ethyl]-4-(phenylmethyl)-(193357-48-1)
• EPA Substance Registry System: Piperidine, 1-[2-[3-(1,3-dioxolan-2-yl)phenoxy]ethyl]-4-(phenylmethyl)-(193357-48-1)

Safety Data

• Hazardous Substances Data: 193357-48-1(Hazardous Substances Data)

Upstream product

• 186191-19-5 m-(2-bromoethyloxy)benzaldehyde 
• 100-83-4 meta-hydroxybenzaldehyde 
• 31252-42-3 4-benzylpyperidine 
• 193357-47-0 3-((2-bromoethyl)oxy)benzaldehyde ethylene acetal 

Relevant articles and documents

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.